The job losses at the CDC are part of a broader reduction of about 5,200 positions across other government public health ...

Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...

Darwin's theory of natural selection provides an explanation for why organisms develop traits that help them survive and reproduce.

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: a shuttling mechanism that helps a complex of proteins pump out a wide ...

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

CAMBRIDGE, MA AND PITTSBURGH, PA / ACCESS Newswire / February 10, 2025 / Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whole genome sequence- (WGS-) based det ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

A study reveals alarming rates of antibiotic resistance in Gram-negative bacteria, highlighting the urgent need for ...

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...